Novel treatment for alcohol use disorder in veterans

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate a new treatment approach for veterans with alcohol use disorder (AUD) by utilizing a computer-delivered Approach Avoidance Training (AAT) to help reduce hazardous drinking and improve recovery outcomes. The intervention focuses on changing implicit tendencies to approach alcohol-related cues, which can hinder recovery. Participants will receive AAT in conjunction with standard VA care, and the study will assess clinical, cognitive, and neural effects of this innovative treatment. The goal is to enhance veterans' engagement in their lives and communities by addressing the high relapse rates associated with AUD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* fluent in English
* primary diagnosis of alcohol use disorders (AUD) with no more than 90 days abstinence from alcohol
* 4-week stability if taking psychotropic medications

Exclusion Criteria:

* lifetime history of psychotic or bipolar disorder
* neurodegenerative or neurodevelopmental disorders
* history of moderate or severe traumatic brain injury or other known neurological condition
* sensory deficits that would preclude completing tasks
* suicidal or homicidal ideation within the past month necessitating urgent higher level care
* concurrent individual psychotherapy or other treatment outside of standard DDRP programming
* conditions unsafe for completing MRI scanning for those completing the scanning component only (e.g., metal in body)

Where it's running

• VA San Diego Healthcare System, San Diego, CA
  San Diego, California, United States Recruiting

Study contacts

• Principal investigator: Jessica A Bomyea, PhD — VA San Diego Healthcare System, San Diego, CA
• Study coordinator: Jessica A Bomyea, PhD
• Email: jessica.bomyea@va.gov
• Phone: (858) 642-3720

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

  This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

  Recruiting Brandeis University · Detroit, Michigan · NCT07724275

• Path180: a computer-based skills program to help teens reduce alcohol use

  This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.

  Recruiting Brown University · Providence, Rhode Island · NCT07713251

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)

  This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.

  Recruiting Phase 3 Centre Hospitalier Universitaire de Nīmes · Bayonne and 7 other locations · NCT07638553

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.